Fundraising Fox
/Companies
Sign in

Cantoni

Leiden, NL · 9 employees on LinkedIn · 1 known investors

Find your way into Cantoni

Cantoni Therapeutics develops small molecule inhibitors targeting nicotinamide N-methyltransferase (NNMT) for the treatment of metabolic and oncology diseases. The company is a discovery and preclinical stage biotech enterprise based in the Netherlands.

AI & Machine LearningBiotechDeep TechHealthtech

Founders & leadership

MVMatthijs van Haren
Matthijs van HarenChief Scientific Officer and Founder
NMNathaniel Martin
Nathaniel MartinFounder and Chair SAB

Investors · 1

In the news

Cantoni Therapeutics secures financing to advance novel non-incretin obesity drug into IND enabling phasefinance.yahoo.com · Sep 2025

Frequently asked questions

What does Cantoni do?
Cantoni Therapeutics develops small molecule inhibitors targeting nicotinamide N-methyltransferase (NNMT) for the treatment of metabolic and oncology diseases. The company is a discovery and preclinical stage biotech enterprise based in the Netherlands.
Who founded Cantoni?
Cantoni was founded by Matthijs van Haren, Nathaniel Martin.
Who are Cantoni's investors?
Cantoni's investors include BOM.
Where is Cantoni headquartered?
Cantoni is headquartered in Leiden, NL.